Intercure Business Summary

Intercure Ltd. (INCR), operating primarily through its subsidiary Canndoc, utilizes a vertically integrated "seed-to-sale" business model to dominate the pharmaceutical-grade medical cannabis market outside North America. The company generates revenue through the research, cultivation, production, and multi-channel distribution of GMP-certified cannabis products, including dried inflorescences and oil-based extracts. Its primary business segments are categorized into Medical Cannabis and Biomed Sector investments, supported by an extensive retail pharmacy chain and strategic international brand partnerships, such as its exclusive agreement with Cookies™. As of early 2026, Intercure has further diversified its technological edge through the acquisition of Botanico Ltd. (ISHI), integrating AI-driven cultivation systems and premium U.S. genetics. In the global landscape, Intercure competes directly with industry titans such as Tilray Brands, Canopy Growth, and Aurora Cannabis, maintaining a distinct competitive advantage through its leadership in the highly regulated Israeli market and its expanding footprint across Europe and the United Kingdom. Leadership is spearheaded by Alexander Rabinovich, who serves as both Chief Executive Officer and Chairman of the Board, having succeeded former Israeli Prime Minister Ehud Barak in the chairmanship in February 2025. The executive team includes Chief Financial Officer Amos Cohen, Chief Operating Officer Rami Levy, and Chief Marketing Officer Moshe Gavrilov, with the recent addition of ISHI founders Omer Layani and Dor Hershkovitz following the 2026 acquisition. Founded in 1994 by Benjamin and Erez Gavish, the company boasts a high-pedigree board featuring experienced directors like Alon Granot and Michael B. Auerbach. Intercure’s institutional backing is robust, with notable positions held by Goldman Sachs, Mirae Asset Global Investments, and significant private investments from lead shareholders Yaron Yakobi and Ynon Hagag, reflecting strong market confidence in its post-war recovery and international expansion strategy.